Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-04 Sale | 2026-05-04 8:42 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $33.2 | $67,529 | 231,558 (Direct) | View |
| 2026-05-01 Sale | 2026-05-01 9:05 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $33.4 | $300,560 | 92,745 (Direct) | View |
| 2026-04-06 Sale | 2026-04-06 7:56 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,034 | $34.57 | $70,315 | 233,592 (Direct) | View |
| 2026-04-01 Sale | 2026-04-01 6:58 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $35.51 | $319,604 | 101,745 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:19 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 6,890 | $29.29 | $201,808 | 36,926 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:18 pm | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,000 | $30 | $180,000 | 207,053 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:16 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $29.72 | $267,485 | 232,350 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 8:15 pm | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 4,068 | $29.53 | $120,108 | 350,282 (Direct) | View |
| 2026-02-02 Sale | 2026-02-02 8:52 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $33.93 | $305,385 | 84,096 (Direct) | View |
| 2026-02-02 Sale | 2026-02-02 8:48 pm | Alkermes plc. | ALKS | Cooke Shane Director | 61,200 | $34.57 | $2,115,673 | 103,744 (Direct) | View |
| 2026-01-08 Sale | 2026-01-08 5:23 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $30 | $150,005 | 93,096 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 4:39 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 4,000 | $28 | $112,000 | 61,740 (Direct) | View |
| 2025-12-03 Sale | 2025-12-05 4:21 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,748 | $30 | $112,447 | 102,096 (Direct) | View |
| 2025-12-01 Sale | 2025-12-01 5:41 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 4,000 | $29.3 | $117,200 | 65,740 (Direct) | View |
| 2025-11-03 Sale | 2025-11-03 4:37 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $30.38 | $273,442 | 109,844 (Direct) | View |
| 2025-10-15 Sale | 2025-10-15 6:47 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,000 | $31.53 | $283,776 | 118,844 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-01 Exercise | 2026-05-01 9:05 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 92,745 (Direct) | View |
| 2026-05-01 Exercise | 2026-05-01 9:05 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 92,745 (Direct) | View |
| 2026-04-11 Exercise | 2026-04-13 5:09 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 3,751 | $0 | 17,307 (Direct) | View |
| 2026-04-11 Tax Withholding | 2026-04-13 5:09 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 901 | $33.36 | 17,307 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-01 6:58 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 101,745 (Direct) | View |
| 2026-04-01 Exercise | 2026-04-01 6:58 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 101,745 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:21 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Reed Joshua SVP, Chief Financial Officer | 97,284 | $0 | 97,284 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:20 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 88,843 | $0 | 88,843 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:19 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 29,209 | $0 | 36,926 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:18 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 97,284 | $0 | 207,053 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:17 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 138,978 | $0 | 138,978 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-04 8:16 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 232,350 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:16 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 121,605 | $0 | 232,350 (Direct) | View |
| 2026-03-02 Exercise | 2026-03-04 8:16 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 232,350 (Direct) | View |
| 2026-03-02 Option Award | 2026-03-04 8:15 pm | N/A 2036-03-02 | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 114,656 | $0 | 350,282 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,747 | $0 | 20,100 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 808 | $30.73 | 20,100 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 5,410 | $0 | 126,588 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 2,403 | $30.73 | 126,588 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,322 | $0 | 257,953 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,695 | $30.73 | 257,953 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:38 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 6,866 | $0 | 107,121 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:38 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,049 | $30.73 | 107,121 (Direct) | View |
| 2026-02-26 Exercise | 2026-02-27 4:37 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 6,866 | $0 | 253,426 (Direct) | View |
| 2026-02-26 Tax Withholding | 2026-02-27 4:37 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 3,049 | $30.73 | 253,426 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:49 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,283 | $0 | 14,952 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:49 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 672 | $32.19 | 14,952 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:48 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,407 | $0 | 119,170 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:48 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 2,845 | $32.19 | 119,170 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:47 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,738 | $0 | 245,419 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:47 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,880 | $32.19 | 245,419 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:46 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 7,689 | $0 | 97,262 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:46 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,414 | $32.19 | 97,262 (Direct) | View |
| 2026-02-23 Exercise | 2026-02-25 5:44 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 7,689 | $0 | 243,567 (Direct) | View |
| 2026-02-23 Tax Withholding | 2026-02-25 5:44 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 3,414 | $32.19 | 243,567 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 4:25 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 5,025 | $0 | 20,031 (Direct) | View |
| 2026-02-19 Tax Withholding | 2026-02-20 4:25 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 979 | $32 | 20,031 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 4:25 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 706 | $32.02 | 20,031 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 4:24 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 12,400 | $0 | 127,337 (Direct) | View |
| 2026-02-19 Tax Withholding | 2026-02-20 4:24 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 2,277 | $32 | 127,337 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 4:24 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 1,869 | $32.02 | 127,337 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 4:23 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 18,197 | $0 | 259,726 (Direct) | View |
| 2026-02-19 Tax Withholding | 2026-02-20 4:23 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 4,130 | $32 | 259,726 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 4:23 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,796 | $32.02 | 259,726 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 4:22 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 16,570 | $0 | 108,316 (Direct) | View |
| 2026-02-19 Tax Withholding | 2026-02-20 4:22 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,407 | $32 | 108,316 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 4:22 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,504 | $32.02 | 108,316 (Direct) | View |
| 2026-02-18 Exercise | 2026-02-20 4:20 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 14,028 | $0 | 254,621 (Direct) | View |
| 2026-02-19 Tax Withholding | 2026-02-20 4:20 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 3,407 | $32 | 254,621 (Direct) | View |
| 2026-02-18 Tax Withholding | 2026-02-20 4:20 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,126 | $32.02 | 254,621 (Direct) | View |
| 2026-02-05 Tax Withholding | 2026-02-06 7:14 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 62,230 | $33.55 | 1,377,740 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 7:14 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 149,580 | $0 | 1,377,740 (Direct) | View |
| 2026-02-05 Tax Withholding | 2026-02-06 7:13 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,389 | $33.55 | 100,946 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 7:13 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 21,127 | $0 | 100,946 (Direct) | View |
| 2026-02-05 Tax Withholding | 2026-02-06 7:12 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,626 | $33.55 | 221,552 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 7:12 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 28,810 | $0 | 221,552 (Direct) | View |
| 2026-02-05 Tax Withholding | 2026-02-06 7:11 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 7,454 | $33.55 | 75,638 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 7:11 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 25,352 | $0 | 75,638 (Direct) | View |
| 2026-02-05 Tax Withholding | 2026-02-06 7:11 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 7,619 | $33.55 | 223,107 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 7:11 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 25,352 | $0 | 223,107 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 8:52 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 84,096 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 8:52 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 84,096 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 8:48 pm | N/A 2026-02-28 | Alkermes plc. | ALKS | Cooke Shane Director | 61,200 | $0 | 103,744 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-02 8:48 pm | N/A N/A | Alkermes plc. | ALKS | Cooke Shane Director | 61,200 | $31.64 | 103,744 (Direct) | View |
| 2026-01-08 Exercise | 2026-01-08 5:23 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 93,096 (Direct) | View |
| 2026-01-08 Exercise | 2026-01-08 5:23 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 93,096 (Direct) | View |
| 2025-12-03 Exercise | 2025-12-05 4:21 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,748 | $0 | 102,096 (Direct) | View |
| 2025-12-03 Exercise | 2025-12-05 4:21 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,748 | $19.34 | 102,096 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-03 4:37 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 109,844 (Direct) | View |
| 2025-11-03 Exercise | 2025-11-03 4:37 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 109,844 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-15 6:47 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $0 | 118,844 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-15 6:47 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,000 | $19.34 | 118,844 (Direct) | View |